Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Angela Ann Giardino, M.D.

Concepts (134)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiology4202221000.590 Why?
Education, Medical, Undergraduate2202410080.570 Why?
Neoplasms, Radiation-Induced220165470.480 Why?
Leukemia, Lymphocytic, Chronic, B-Cell3201815960.460 Why?
Hemangiosarcoma120162390.460 Why?
Students, Medical2202418620.430 Why?
Lymphoma, Large B-Cell, Diffuse2201213780.400 Why?
Lymphoma4201618770.380 Why?
Lymph Nodes2201434740.380 Why?
Empyema, Pleural12011620.380 Why?
Education, Medical1202217210.360 Why?
Menisci, Tibial120122690.350 Why?
Diagnostic Imaging9201535070.340 Why?
Headache1201712260.340 Why?
Abdomen1201411180.300 Why?
Tibia1201210770.280 Why?
Pleural Neoplasms120116070.270 Why?
Medical Oncology1201722650.250 Why?
Bone Neoplasms3201225290.230 Why?
Immunotherapy1201744450.200 Why?
Computer-Assisted Instruction120243650.190 Why?
Vincristine2201210390.170 Why?
Educational Measurement2202412100.160 Why?
Melanoma1201755100.160 Why?
Tomography, X-Ray Computed102018201290.160 Why?
Positron-Emission Tomography7201362340.160 Why?
Oncology Service, Hospital12017570.140 Why?
Prednisone2201215740.140 Why?
Cyclophosphamide2201222420.130 Why?
Doxorubicin2201222340.130 Why?
Hematologic Neoplasms4201518320.120 Why?
Antineoplastic Combined Chemotherapy Protocols42017115240.110 Why?
Lymphoma, Mantle-Cell120162330.110 Why?
Curriculum2202436050.110 Why?
Contrast Media6201653000.100 Why?
Uterine Cervical Neoplasms2201620200.100 Why?
Neuroectodermal Tumors, Primitive, Peripheral12011450.100 Why?
Splenic Neoplasms120111000.100 Why?
Radiographic Image Interpretation, Computer-Assisted1201811840.100 Why?
Fibromatosis, Aggressive120111180.090 Why?
Breast Neoplasms32017208220.090 Why?
Radiography, Abdominal120145370.090 Why?
Sacrum120112880.090 Why?
Carcinoma, Basal Cell120155450.090 Why?
Neoplastic Syndromes, Hereditary120112410.080 Why?
Hydrocortisone1201718260.080 Why?
Carcinoma, Small Cell120114200.080 Why?
Transplantation Conditioning1201615980.080 Why?
Chordoma120113590.080 Why?
Sirolimus1201615640.080 Why?
Neoplasm Recurrence, Local3201692390.080 Why?
Humans3020247443430.080 Why?
Antibodies, Monoclonal, Murine-Derived120116930.080 Why?
Urologic Neoplasms120113180.070 Why?
Central Nervous System Neoplasms120158950.070 Why?
Fluorodeoxyglucose F182201220160.070 Why?
Osteosarcoma120118810.070 Why?
Amyloidosis120127950.060 Why?
Lymph Node Excision1201112610.060 Why?
Radiotherapy1201115330.060 Why?
Mammography3200124760.060 Why?
Referral and Consultation1201735280.060 Why?
Endometrial Neoplasms1201313530.060 Why?
Gastrointestinal Neoplasms120119900.060 Why?
Graft vs Host Disease1201629570.060 Why?
Neoplasm Metastasis4201648510.050 Why?
Female1320173801940.050 Why?
Magnetic Resonance Imaging42017354210.050 Why?
Middle Aged720172133830.040 Why?
Sarcoma1201118970.040 Why?
Carcinoma, Hepatocellular1201122140.040 Why?
Neoplasm Staging42016110310.040 Why?
Hematopoietic Stem Cell Transplantation1201654420.040 Why?
Immunohistochemistry12011113660.040 Why?
Carcinoma, Renal Cell1201131430.030 Why?
Aged620161632800.030 Why?
Liver Neoplasms1201142530.030 Why?
Kidney1201171860.030 Why?
Skin Neoplasms1201556860.030 Why?
Breast Diseases119984430.030 Why?
Treatment Outcome22012631140.030 Why?
Kidney Neoplasms1201142620.030 Why?
Learning1202417130.030 Why?
Carcinoma, Intraductal, Noninfiltrating120019490.030 Why?
Cytarabine120166920.030 Why?
Radiographic Image Enhancement119978850.030 Why?
Multiple Endocrine Neoplasia12011250.030 Why?
Fibromatosis, Abdominal12011240.030 Why?
Tacrolimus120167430.030 Why?
Viscera120121390.030 Why?
Li-Fraumeni Syndrome120111140.020 Why?
von Hippel-Lindau Disease120111520.020 Why?
Interprofessional Relations1201710110.020 Why?
Joints120123260.020 Why?
Male620163501180.020 Why?
Remission Induction1201623860.020 Why?
Genetic Predisposition to Disease12011174460.020 Why?
Vascular Neoplasms120111750.020 Why?
Methotrexate1201617270.020 Why?
Breast1199819690.020 Why?
Fluorine Radioisotopes120124420.020 Why?
Prognosis32016290630.020 Why?
Prostatic Neoplasms12011111240.020 Why?
Fluoroscopy120129240.020 Why?
Neurofibromatoses120112990.020 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis120113790.020 Why?
Decision Support Techniques1201719560.020 Why?
Patient-Centered Care1201714390.020 Why?
Biopsy1199867560.020 Why?
Disease-Free Survival1201668950.020 Why?
Radiography1201570230.010 Why?
Lymphatic Metastasis1201129240.010 Why?
Adult520162140550.010 Why?
Adolescent32016857810.010 Why?
Radiopharmaceuticals1201226450.010 Why?
Protein Kinase Inhibitors1201855350.010 Why?
Survival Rate12016127880.010 Why?
Echocardiography1201251020.010 Why?
Myocardium1201247760.010 Why?
Heart1201244670.010 Why?
Diagnosis, Differential12011129590.010 Why?
Sensitivity and Specificity12011147220.010 Why?
ROC Curve1200135270.010 Why?
Lung1201298560.010 Why?
Reproducibility of Results12011199050.010 Why?
Diagnostic Tests, Routine119987830.010 Why?
Inflammation12012106380.010 Why?
Phantoms, Imaging1199724800.010 Why?
Lung Neoplasms12011131020.000 Why?
Young Adult12011564300.000 Why?
Brain12012263850.000 Why?
Risk Factors12011722900.000 Why?
Retrospective Studies22001774490.000 Why?
Prospective Studies11998532880.000 Why?
Giardino's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (134)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.